A Nurse’s Guide to Hormones and Mental Health: Menstrual Tracking Insights

A Nurse’s Guide to Hormones and Mental Health: Menstrual Tracking Insights

SUMMARY: 
Hormonal fluctuations across the menstrual cycle don't just affect physical health—they have measurable, clinically significant mental health implications that are still widely misunderstood, underdiagnosed, and often dismissed in practice. This episode breaks down the hormone-mood connection, explains the phases of the menstrual cycle and what's happening neurochemically in each, and explores how menstrual tracking can be used as a clinical tool to identify patterns, differentiate conditions, and guide care.

---
Nurses may be able to complete an accredited CE activity featuring content from this podcast and earn CE hours provided from Elite Learning by Colibri Healthcare. For more information, click here

Already an Elite Member? Login here

Learn more about CE Podcasts from Elite Learning by Colibri Healthcare

View Episode Takeaways

View this podcast course on Elite Learning

Series: A Nurse’s Guide to Hormones and Mental Health: Menstrual Tracking Insights

Transcript

Elite Learning Podcast

Hormones and Mental Health: Menstrual Tracking Insights

Hormonal fluctuations affect mental health in ways that are still widely misunderstood and underdiagnosed. This episode unpacks the science, the clinical tools, and what better-informed care looks like.

Listen time: ~60 minutes
👥 Audience: RNs, APRNs, NPs, mental health providers, primary care clinicians
🎧 Listen now: elitelearning.com/ce-podcasts

🗣🗣 Featured Voices
Host: Dr. Candace Pierce, DNP, RN, CNE, COI Faculty with Elite Learning by Colibri Healthcare, nurse educator, and advocate for women’s health and clinical education.

Guest: Dr. Erica Ramey Mental health clinician, educator, and specialist in reproductive psychiatry and hormone-related mood disorders.


☑ What You’ll Learn
The four phases of the menstrual cycle and their mental health-relevant hormonal effects

How estrogen, progesterone, allopregnanolone, serotonin, and GABA interact to influence mood

Why some people experience dramatic cycle-driven mood changes while others do not

The clinical distinctions between PMS, PMDD, and premenstrual exacerbation (PME)

How to use prospective menstrual tracking as a diagnostic tool

Pharmacological and non-pharmacological treatment strategies for PMDD

How medical gaslighting and training gaps contribute to a 20-year diagnostic delay

💡 Key Takeaways
The menstrual cycle is data, not drama. When tracked and interpreted correctly, it can shorten diagnostic windows and redirect treatment.

PMDD affects an estimated 31 million women globally, yet most go undiagnosed for an average of 20 years after symptoms begin.

Hormone levels in PMDD are typically normal. The issue is neurobiological sensitivity to normal hormonal fluctuations, not abnormal levels.

Bipolar 2, GAD, treatment-resistant depression, and ADHD are among the most commonly misattributed diagnoses that may actually be cycle-driven.

To diagnose PMDD, at least two months of prospective daily symptom tracking is required. Recall alone is not sufficient.

SSRIs work differently in PMDD than in depression. They can be effective within 1-2 days and used only during the luteal phase.

Sleep is the foundation. If sleep is poor, nothing else gets better, regardless of diagnosis or treatment.

Only about 40% of U.S. psychiatry residency directors consider reproductive psychiatry significant enough to include in training.

Cycle tracking should be integrated into care for patients with mood disorders, ADHD, autoimmune conditions, and suicide risk.

🔁 The Menstrual Cycle at a Glance

Phase: Follicular
Timing: Days 1-13
Mental Health Relevance: Estrogen rises; serotonin and dopamine increase. Best mood, energy, focus, and cognitive performance.

Phase: Ovulation
Timing: Day 14
Mental Health Relevance: Brief estrogen peak; libido and mood peak for most. Some may experience a mood dip as estrogen drops sharply.

Phase: Luteal
Timing: Days 15-28
Mental Health Relevance: Progesterone rises then drops sharply. Last 7-10 days carry highest risk for PMS, PMDD, and PME symptoms.

Phase: Menstruation
Timing: Day 1 of period
Mental Health Relevance: Hormonal trigger passes; significant symptom relief for those with PMDD. Cycle resets toward follicular phase.



📋 PMS vs. PMDD vs. PME: Getting the Diagnosis Right

PMS
Definition: Common premenstrual symptoms without significant impairment
Impairment: Mild to moderate; does not significantly disrupt functioning
Treatment: Lifestyle: exercise, calcium, sleep, stress reduction

PMDD
Definition: DSM-5 depressive disorder with severe premenstrual symptoms causing functional impairment
Impairment: Significant impairment in relationships, work, school, or role functioning
Treatment: SSRIs (luteal phase), hormonal therapy, CBT, lifestyle measures

PME
Definition: Worsening of an existing psychiatric condition in the premenstrual period
Impairment: Destabilization of an otherwise managed condition
Treatment: Dose adjustment of existing medications during luteal phase; close monitoring


📖 PMDD DSM-5 Diagnostic Criteria

To meet criteria, 5 or more of the following 11 symptoms must occur in the week before menstruation, remit within days of onset, and cause significant functional impairment. At least one must be a core affective symptom.

Core Affective Symptoms (at least one required):

• Affective lability (mood swings)
• Marked irritability or anger
• Depressed mood
• Significant anxiety or tension

Additional Symptoms:

• Difficulty concentrating
• Fatigue or low energy
• Changes in appetite (including cravings or overeating)
• Sleep changes (insomnia or hypersomnia)
• Feeling overwhelmed or out of control
• Physical symptoms: bloating, breast tenderness, water retention

Note: Symptoms must be tracked prospectively for at least 2 cycles to confirm diagnosis. The gold standard tool is the Daily Record of Severity of Problems (DRSP).


📱 Menstrual Tracking as a Clinical Tool

• Minimum ask: First day of menstruation each cycle. This alone allows clinicians to plot symptoms against cycle timing.
• Ideal tracking includes: Cycle dates, mood symptoms (irritability, depression, anxiety, suicidal ideation), sleep changes, and degree of functional impairment.
• Gold standard tool: Daily Record of Severity of Problems (DRSP). Aligned with DSM-5 criteria. A 30% or greater increase in symptom severity in the luteal phase is clinically significant.
• Apps to consider: Clue, Ovia, Flo, or the built-in health app. Choose based on what the patient will actually use consistently. Always review app privacy policies before recommending.
• Key clinical question: Do symptoms follow a predictable cycle pattern? Do they remit after menstruation begins?

👥 Populations Where Cycle Tracking Is Especially Important

• Women with treatment-resistant depression or bipolar 2 disorder
• Patients with ADHD (cycle phase significantly affects symptom severity and medication effectiveness)
• Women with autoimmune or inflammatory conditions
• Patients with a history of self-harm or suicidal ideation
• Women new to mental health care in their late 30s or early 40s (consider perimenopause)
• Anyone with a substance use history (late luteal phase increases self-medication risk)

💊 Treatment Approaches

Pharmacological:

• SSRIs/SNRIs (luteal phase dosing): Effective within 1-2 days in PMDD due to GABA normalization, not serotonin upregulation. Can be taken only during the second half of the cycle.
• Continuous SSRI use: An option for patients who prefer consistent dosing or have comorbid mood disorders.
• Dose adjustment for PME: Temporarily increasing the dose of an existing medication during the luteal phase may reduce exacerbation.
• Hormonal contraceptives: Can suppress cycle-related fluctuations but may affect mood variably. Counsel patients individually.
• GnRH agonists: Reserved for severe, refractory PMDD. Suppress ovarian function entirely.

Non-Pharmacological:

• Sleep: The foundation of mental health. No treatment works well without adequate sleep.
• Exercise: Strongest non-pharmacological evidence base. Reduces symptoms via neurotransmitter activity and inflammation reduction.
• Calcium supplementation: ~1,000-1,200 mg/day has evidence for PMS and PMDD symptom reduction.
• Reduce alcohol: Especially in the luteal phase. Alcohol worsens mood dysregulation and does not produce the calming effect patients seek.
• CBT: Effective for managing cognitive and behavioral responses to cycle-related mood changes.
• Cycle-informed scheduling: Encourage patients to plan demanding tasks, social commitments, and difficult conversations in the follicular phase when possible.
  
  

⚠ Suicide Risk and Cycle-Informed Safety Planning

• Suicidal ideation and attempts are more likely in the late luteal phase (approximately 4 days before menstruation onset).
• If a cycle-related pattern is identified, schedule therapy appointments to align with the highest-risk week.
• Build safety plans proactively. Identify support contacts and give them a heads-up about the anticipated difficult week.
• For patients in substance use recovery, engage sponsors or support networks in advance of the luteal phase.
• Predictability is protective. If we can anticipate the risk, we can plan around it.

🚩 Medical Gaslighting and the 20-Year Diagnostic Gap

• "This is just part of being a woman." Normalizing severe symptoms delays diagnosis and treatment.
• Women are often told hormone levels are normal and therefore nothing is wrong. But PMDD is about sensitivity to normal hormonal changes, not abnormal levels.
• Symptoms beginning in adolescence are frequently dismissed or attributed to personality, stress, or anxiety.
• Siloed care (OB/GYN, psychiatry, primary care) means no one specialty takes ownership of the hormone-mood connection.
• Only ~40% of U.S. psychiatry residency directors consider reproductive psychiatry important enough to include in training.
• Closing the gap requires asking about cycles, validating symptoms, and integrating tracking into routine care across all specialties.

✅ Do This Next

• Start asking patients about their menstrual cycle as part of every mental health intake, not just to rule out pregnancy.
• Introduce prospective cycle tracking at the first visit. Even just the first day of menstruation is a meaningful starting point.
• Familiarize yourself with the DRSP (Daily Record of Severity of Problems) and how to interpret it against DSM-5 PMDD criteria.
• Review your current patients with treatment-resistant depression, bipolar 2, or ADHD through a cycle-informed lens.
• Counsel patients on luteal-phase lifestyle adjustments: sleep, alcohol reduction, exercise, and realistic scheduling.

🧠 Clinical Terminology Toolkit

• Follicular Phase: Days 1-13 of the cycle. Estrogen rises, supporting serotonin and dopamine activity. Associated with improved mood, energy, and cognition.
• Luteal Phase: Days 15-28. Progesterone rises then drops sharply. The highest-risk window for PMS, PMDD, and PME symptoms.
• Allopregnanolone: A metabolite of progesterone that normally produces a calming GABA effect. In PMDD, this response is paradoxical, causing anxiety and dysphoria instead.
• DRSP: Daily Record of Severity of Problems. The gold standard prospective tracking tool, aligned with DSM-5 PMDD criteria.
• PME: Premenstrual Exacerbation. A predictable worsening of an existing psychiatric condition during the premenstrual period.
• Luteal-Phase Dosing: Prescribing SSRIs only during the second half of the cycle for PMDD. Effective within 1-2 days due to GABA normalization rather than serotonin upregulation.
• Neurobiological Sensitivity: The mechanism underlying PMDD. Hormone levels are normal; the individual’s brain responds more intensely to normal hormonal fluctuations.

Conversation Starter

“The next time a patient mentions mood changes that seem to come and go, ask them about their cycle. That one question might be what changes their quality of life.”